Compare Cardinal Health Inc (CAH) vs Diamondback Energy Inc (FANG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Diamondback Energy Inc — how do they compare? Cardinal Health Inc trades at $224.5 (market cap $53.89B), while Diamondback Energy Inc trades at $189.43 (market cap $53.64B). The key difference: Cardinal Health Inc and Diamondback Energy Inc are close in size by market cap, and Diamondback Energy Inc pays the higher dividend (2.31%). Which is the better fit depends on your goals.
| CAH | FANG | |
|---|---|---|
Market Cap | $53.89B | $53.64B |
Sector | Health | Energy |
52-Week High | $239.71 | $213.69 |
52-Week Low | $146.04 | $134.53 |
Enterprise Value | $58.87B | $67.37B |
Dividend Yield | 0.89% | 2.31% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
Diamondback Energy (FANG) trades at $191.6, up 4.48% today, with a bullish technical signal and strong analyst support. The stock shows robust revenue growth, reaching $14.93B in 2025, though net income margins have compressed. Recent earnings beat expectations in Q1 2026, and the company maintains a solid balance sheet with manageable debt levels. A dividend of $1.10 was recently paid, enhancing shareholder returns.
FANG presents a favorable outlook with a consensus price target of $234.50, implying significant upside. However, risks include volatile oil prices, declining profit margins, and execution challenges in a competitive energy sector. The stock's high P/E ratio of 195.51 warrants caution, but strong cash flow and institutional bullishness support a positive investment case for growth-oriented investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Diamondback Energy Inc
Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2021, the company reported net proven reserves of 1.8 billion barrels of oil equivalent. Net production averaged about 375,000 barrels per day in 2021, at a ratio of 60% oil, 20% natural gas liquids, and 20% natural gas.
Read more on FANG →
